Radiotherapy of six fractions per a week for T1 glottic carcinoma

T. Akai, S. Nomoto, K. Hayashi, Y. Kuwabara, K. Yoshimitsu, T. Sueta, T. Nakagawa, Y. Akita, K. Jingu, K. Nakamura

Research output: Contribution to journalArticlepeer-review

Abstract

Radiotherapy for T1 glottic carcinoma is important to preserve laryngeal functions. Local control rate of accelerated radiotherapy, radiotherapy of six fractions per a week and hyperfractionated radiotherapy are shown to be better compared with the radiotherapy of five fractions per a week in the past reports. Twenty-six cases were performed the radiotherapy of six fractions per a week for T1 glottic carcinoma. Five year local control rate was 88.3% and was treatable without the adverse events. Radiotherapy of six fractions per a week with daily dose of 2Gy was feasible, these toxicities were acceptable.

Original languageEnglish
Pages (from-to)1347-1353
Number of pages7
JournalJapanese Journal of Clinical Radiology
Volume58
Issue number10
Publication statusPublished - Oct 2013

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Radiotherapy of six fractions per a week for T1 glottic carcinoma'. Together they form a unique fingerprint.

Cite this